Investment Visual

MRK

Merck & Co., Inc.

Revenue by segment

2025, ended Dec 31, 2025

Earlier:

Segments by fiscal year

Segments by fiscal year
Line, in USD	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Animal Health	6.35B	5.88B	5.63B	5.55B	5.57B	4.70B	4.39B	4.21B	3.88B	3.48B	—	—	—	—	—	—	—
Corporate, Non-Segment	0.52B	0.89B	0.91B	1.73B	0.38B	0.18B	0.45B	0.14B	0.46B	0.79B	1.05B	0.44B	0.20B	0.25B	0.33B	—	—
	58.1B	57.4B	53.6B	52.0B	42.8B	36.6B	34.3B	37.9B	35.8B	35.5B	38.4B	41.8B	43.8B	47.0B	47.7B	46.0B	27.4B
Operating Segments	—	—	—	—	—	—	—	—	—	—	—	—	—	47.0B	47.7B	—	27.4B
Pharmaceutical	58.1B	57.4B	53.6B	52.0B	42.8B	36.6B	34.1B	37.7B	35.4B	35.2B	34.8B	36.0B	37.4B	40.6B	41.3B	—	—
Other segments	—	—	—	—	—	23M	0.18B	0.25B	0.40B	0.39B	3.67B	5.76B	6.40B	6.41B	6.43B	6.16B	2.11B
Primary Care and Women’s Health	—	—	—	—	—	—	—	—	—	—	—	—	—	18.6B	19.4B	18.4B	—
Hospital and Specialty	—	—	—	—	—	—	—	—	—	—	—	—	—	9.49B	9.60B	8.72B	—
Other pharmaceutical	—	—	—	—	—	—	—	—	—	—	—	—	—	4.33B	4.27B	4.62B	—
Diversified Brands	—	—	—	—	—	—	—	—	—	—	—	—	—	3.43B	4.15B	4.01B	—
Vaccines	—	—	—	—	—	—	—	—	—	—	—	—	—	4.74B	3.89B	3.50B	—
segment sales	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	45.4B	—
Pharmaceutical segment sales	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	39.3B	25.2B
Other	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	561M	—
Unallocated Amount To	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	78M
Total	65.0B	64.2B	60.1B	59.3B	48.7B	41.5B	39.1B	42.3B	40.1B	39.8B	39.5B	42.2B	44.0B	47.3B	48.0B	46.0B	27.4B